ATE263160T1 - Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung - Google Patents

Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung

Info

Publication number
ATE263160T1
ATE263160T1 AT01969391T AT01969391T ATE263160T1 AT E263160 T1 ATE263160 T1 AT E263160T1 AT 01969391 T AT01969391 T AT 01969391T AT 01969391 T AT01969391 T AT 01969391T AT E263160 T1 ATE263160 T1 AT E263160T1
Authority
AT
Austria
Prior art keywords
tocotrienolquinone
antihypercholesterol
effect
sup
cycling products
Prior art date
Application number
AT01969391T
Other languages
English (en)
Inventor
Kai-Uwe Baldenius
Hartwig Schroeder
Klaus Kraemer
Karin Schein
Rainer Stuermer
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of ATE263160T1 publication Critical patent/ATE263160T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01969391T 2000-07-14 2001-07-13 Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung ATE263160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034233A DE10034233A1 (de) 2000-07-14 2000-07-14 Tocotrienolchinon-Cyclisierungsprodukte
PCT/EP2001/008163 WO2002006261A1 (de) 2000-07-14 2001-07-13 Tocotrienolchinon-zyklisierungsprodukte mit antihypercholesterin wirkung

Publications (1)

Publication Number Publication Date
ATE263160T1 true ATE263160T1 (de) 2004-04-15

Family

ID=7648895

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01969391T ATE263160T1 (de) 2000-07-14 2001-07-13 Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung

Country Status (10)

Country Link
US (1) US6977270B2 (de)
EP (1) EP1301501B1 (de)
JP (1) JP2004504313A (de)
CN (1) CN1441793A (de)
AT (1) ATE263160T1 (de)
AU (1) AU2001289659A1 (de)
DE (2) DE10034233A1 (de)
DK (1) DK1301501T3 (de)
ES (1) ES2218448T3 (de)
WO (1) WO2002006261A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120046237A1 (en) * 1998-04-08 2012-02-23 Theoharides Theoharis C Compositions for protection against superficial vasodilator flush syndrome, and methods of use
PL1888059T3 (pl) 2005-06-01 2015-06-30 Bioelectron Tech Corp Środki terapeutyczne aktywne wobec układów redoks do leczenia chorób mitochondrialnych i innych zaburzeń oraz modulacja biomarkerów energetycznych
WO2007035496A1 (en) * 2005-09-15 2007-03-29 Edison Pharmaceuticals, Inc. Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
MX2011002318A (es) 2008-09-10 2011-05-10 Edison Pharmaceuticals Inc Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox.
PT2963006T (pt) * 2008-10-28 2018-12-14 Bioelectron Tech Corp Composição contendo alfa-tocotrienol quinona e seus intermediários
EP2424495B1 (de) 2009-04-28 2018-01-17 Bioelectron Technology Corporation Behandlung von erblicher leber-optikus-neuropathie und dominanter optikus-neuropathie mit tocotrienol-chinonen
SI2470168T1 (en) * 2009-08-26 2018-05-31 Bioelectron Technology Corporation Procedures for the prevention and treatment of brain ischemia
WO2013013078A1 (en) 2011-07-19 2013-01-24 Edison Pharmeceuticals, Inc. Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
ES2700983T3 (es) 2012-06-08 2019-02-20 Univ Ohio State Tratamiento de lesión cicatricial usando tocotrienol
WO2017106786A1 (en) 2015-12-16 2017-06-22 Bioelectron Technology Corporation Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
CA3008849A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
KR910007523A (ko) * 1989-10-04 1991-05-30 브리스톨-마이어즈 스퀴브 컴페니 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올
CA2050514A1 (en) * 1990-09-14 1992-03-15 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
CA2096496A1 (en) * 1992-05-29 1993-11-30 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
US5318993A (en) * 1993-04-16 1994-06-07 Bristol-Myers Squibb Company Antihyperlipidemic benzoquinones
EP0669132A1 (de) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Kombinationspräparat von Vitamine E und Acetylsalicylate zur Behandlung und Prophylaxis des Atherosclerosis
JP3926888B2 (ja) 1997-05-27 2007-06-06 株式会社カネカ コレステロール低下剤

Also Published As

Publication number Publication date
ES2218448T3 (es) 2004-11-16
AU2001289659A1 (en) 2002-01-30
US20040116715A1 (en) 2004-06-17
WO2002006261A1 (de) 2002-01-24
EP1301501B1 (de) 2004-03-31
DE50101861D1 (de) 2004-05-06
CN1441793A (zh) 2003-09-10
DK1301501T3 (da) 2004-07-19
EP1301501A1 (de) 2003-04-16
JP2004504313A (ja) 2004-02-12
US6977270B2 (en) 2005-12-20
DE10034233A1 (de) 2002-01-24

Similar Documents

Publication Publication Date Title
PT1193270E (pt) Pirrolobenzodiazepinas
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ES2172864T3 (es) 2-metoxibenzofenonas fungicidas.
DE60012188D1 (de) Fungizide
ECSP034896A (es) Derivados aromaticos de acidos dicarboxilicos
PT1453512E (pt) Derivados de acetileno tendo actividade antagonistica do mglur 5
ATE228133T1 (de) Fungizide trifluorophenyltriazolopyrimidine
DK1385514T3 (da) Spiroinden- og spiroindanforbindelser
DK1385515T3 (da) Spiropyrazole forbindelser
ATE288900T1 (de) Substituierte benzoylcyclohexandione
ATE263160T1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
SE0100326D0 (sv) New compounds
WO2002011737A3 (en) Anti-inflammatory medicament
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
SE9903290D0 (sv) Novel compounds
DK1204659T3 (da) Serotonerge benzofuraner
TR199901017A2 (xx) B�cek ilac� terkibi.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
SE0003795D0 (sv) Pharmaceutically useful compounds
DE69419661D1 (de) Thiazolotriazol- und Thiazolodiazolderivate mit fungizider Aktivität
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
IT1262952B (it) Tetraalchilpiperidine, loro preparazione e loro impiego come stabilizzanti alla luce. (caso 153-5502)
NO20025410L (no) Anvendelse av stannylener og germylener som polymerisasjonskatalysatorer for heterocykler
TH29525B (th) ฟีนิลซับสทิทิวเท็ด 4-เอซาสเตียรอยด์ ฟลูออโรเดอริเวทีฟ

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee